The Biden administration has formally established the Medicare Drug Rebate and Negotiations Group to implement Medicare drug price negotiations and the inflation rebate program authorized under the Inflation Reduction Act of 2022.
Operating within the Center for Medicare, the new group, and the reorganization it required, was approved by HHS Secretary
The Inflation Reduction Act (H.R. 5376), signed by President
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.